1,534
Views
5
CrossRef citations to date
0
Altmetric
Infectious Diseases

A systematic analysis of and recommendations for public health events involving brucellosis from 2006 to 2019 in China

, , , , &
Pages 1859-1866 | Received 30 Mar 2022, Accepted 16 Jun 2022, Published online: 04 Jul 2022

References

  • Lai SJ, Chen QL, Li ZJ. Human brucellosis: an ongoing global health challenge. China CDC Weekly. 2021;3(6):120–123.
  • Pappas G. The changing Brucella ecology: novel reservoirs, new threats. Int J Antimicrob Agents. 2010;36(1):S8–S11.
  • Saddique A, Ali S, Akhter S, et al. Acute febrile illness caused by Brucella abortus infection in humans in Pakistan. Int J Env Res Public Health. 2019;16(21):4071.
  • El-Sayed A, Awad W. Brucellosis: evolution and expected comeback. Int J Vet Sci Med. 2018;6:S31–S35.
  • Eschenbrenner M, Wagner MA, Horn TA, et al. Comparative proteome analysis of Brucella melitensis vaccine strain rev 1 and a virulent strain, 16M. J Bacteriol. 2002;184(18):4962–4970.
  • Jiang W, Chen J, Li Q, et al. Epidemiological characteristics, clinical manifestations and laboratory findings in 850 patients with brucellosis in Heilongjiang Province, China. BMC Infect Dis. 2019;19(1):439.
  • Young EJ, Hasanjani Roushan MR, Shafae S, et al. Liver histology of acute brucellosis caused by Brucella melitensis. Hum Pathol. 2014;45(10):2023–2028.
  • Sewell DL. Laboratory-acquired infections: are microbiologists at risk? Clin Microbiol Newsl. 2006;28(1):1–6.
  • Al Dahouk S, Nöckler K. Implications of laboratory diagnosis on brucellosis therapy. Expert Rev Anti Infect Ther. 2011;9(7):833–845.
  • Fiori PL, Mastrandrea S, Rappelli P, et al. Brucella abortus infection acquired in microbiology laboratories. J Clin Microbiol. 2000;38(5):2005–2006.
  • Robichaud S, Libman M, Behr M, et al. Prevention of laboratory-acquired brucellosis. Clin Infect Dis. 2004;38(12):e119–e122.
  • Yagupsky P, Morata P, Colmenero JD. Laboratory diagnosis of human brucellosis. Clin Microbiol Rev. 2019;33(1):e00073.
  • Begum F, McGregor A, Kava S, et al. A laboratory Brucella exposure in a UK hospital: a Swiss cheese model? J Hosp Infect. 2019;103(4):477–478.
  • Knudsen A, Kronborg G, Dahl Knudsen J, et al. Laboratory exposure to Brucella melitensis in Denmark: a prospective study. J Hosp Infect. 2013;85(3):237–239.
  • Araj GF. Update on laboratory diagnosis of human brucellosis. Int J Antimicrob Agents. 2010;36(1):S12–S17.
  • Xu N, Dong X, Yao Y, et al. Improved early detection of focal brucellosis complications with anti-Brucella IgG. J Clin Microbiol. 2020;58(10):e00903.
  • Hvistendah M. Chinese University Fires Administrators, Offers Compensation After Lab Accident, Science. 2011 [cited 2019 Dec 28]. Available from: https://www.sciencemag.org/news/2011/09/chinese-university-firesadministrators-offers-compensation-after-lab-accident
  • Zhang P, Fang C, Cui BY. A report of a brucellosis outbreak caused by vaccination. Dis Surv. 2018;33(3):222–224.
  • Jiang H, Feng L, Lu, JX. Updated guidelines for the diagnosis of human brucellosis — China, 2019. China CDC Weekly. 2020;2(26):487–489.
  • Times Group. 10,528 residents test positive for brucellosis in Lanzhou after Brucella leakage in local factory. 2020 [cited 2020 Dec 3]. Available from: https://www.globaltimes.cn/content/1208864.shtml
  • Times Group. Victims of NW China’s brucellosis incident to file group lawsuit. 2020 [cited 2020 Dec 9]. Available from: https://www.globaltimes.cn/content/1209452.shtml
  • Lina SMM, Kunasekaran MP, Moa A. Brucellosis outbreak in China, 2019. Global Biosecurity, 2021;3(1). http://doi.org/10.31646/gbio.108.
  • Blaney D, Bosserman E, Bui D, et al. editors. Brucella laboratory exposures in the United States, 2008. Arlington (VA): Infectious Diseases Society of America; 2009.
  • Ackelsberg J, Liddicoat A, Burke T, et al. Brucella exposure risk events in 10 clinical laboratories, New York city, USA, 2015 to 2017. J Clin Microbiol. 2020;58(2):e01096.
  • Yang H, Zhang S, Wang T, et al. Epidemiological characteristics and spatiotemporal trend analysis of human brucellosis in China, 1950-2018. Int J Env Res Public Health. 2020;17(7):2382.
  • Yagupsky P, Baron EJ. Laboratory exposures to brucellae and implications for bioterrorism. Emerg Infect Dis. 2005;11(8):1180–1185.
  • Pike RML. Laboratory associated infections: summary and analysis of 3921 cases. Health Lab Sci. 1976;13(2):105–114.
  • Stephanie N, Richard G, Molly K, et al. Laboratory-acquired brucellosis. Emerging Infect Dis. 2004;10(10):1848–1850.
  • Bouza E, Sánchez-Carrillo C, Hernangómez S, et al. Laboratory-acquired brucellosis: a Spanish national survey. J Hosp Infect. 2005;61(1):80–83.
  • Griffith J, Sullivan M, Howell J. Laboratory-acquired brucellosis–Indiana and Minnesota, 2006. Ped Infect Dis J. 2008;27(2):39–42.
  • Xie X. Orally administrable brucellosis vaccine: Brucella suis strain 2 vaccine. Vaccine. 1986;4(4):212–216.
  • Wang X, Lin P, Li Y, et al. Brucella suis vaccine strain 2 induces endoplasmic reticulum stress that affects intracellular replication in goat trophoblast cells in vitro. Front Cell Infect Microbiol. 2016;6:19.
  • Osman AE, Hassan AN, Ali AE, et al. Brucella melitensis biovar 1 and Brucella abortus S19 vaccine strain infections in milkers working at cattle farms in the Khartoum area, Sudan. PLoS One. 2015;10(5):e0123374.
  • Liu SJ. Ulanqab confirms that more than 100 epidemic prevention personnel have been infected with Brucella spp. China Animal Health; 2011. http://zgdwbj.com/archives/10152 (in Chinese).
  • Liu ZG, Di DD, Wang M, et al. MLVA genotyping characteristics of human Brucella melitensis isolated from Ulanqab of Inner Mongolia. Front Microbiol. 2017;8:6.
  • Wallach JC, Ferrero MC, Victoria Delpino M, et al. Occupational infection due to Brucella abortus S19 among workers involved in vaccine production in Argentina. Clin Microbiol Infect. 2008;14(8):805–807.
  • Rahman AKMA, Saegerman C, Dirk B, et al. editors. Brucella abortus is circulating in both, man and animals of Bangladesh. Paper presented at the 14th International Conference of the Association of Institutions for Tropical Veterinary Medicine; 2013 August 24–28; Johannesburg, South Africa.
  • Mascarenhas DR, Schwarz DGG, Fonseca Júnior AA, et al. Validation of real-time PCR technique for detection of Mycobacterium bovis and Brucella abortus in bovine raw milk. Braz J Microbiol. 2020;51(4):2095–2100.
  • Gwinn M, MacCannell DR, Khabbaz RF. Integrating advanced molecular technologies into public health. J Clin Microbiol. 2017;55(3):703–714.
  • Gwinn M, Maccannell D, Armstrong GL. Next-generation sequencing of infectious pathogens. J American Med Assoc. 2019;321(9):893–894.